[Use of the lysosomal-cationic test for the prognosis of postoperative suppurative complications in patients with infectious endocarditis].
Kucherenko
A D
AD
Seleznev
N S
NS
Mazing
Iu A
IuA
D023181:Antimicrobial Cationic Peptides; D001770:Blood Bactericidal Activity / Q000276:immunology*; D001798:Blood Proteins / Q000032:analysis* / Q000172:deficiency; D004697:Endocarditis, Bacterial / Q000276:immunology / Q000601:surgery*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications* / Q000175:diagnosis; D007159:Immunologic Tests / Q000379:methods; D008247:Lysosomes / Q000276:immunology; D009504:Neutrophils / Q000276:immunology*; D011379:Prognosis; D013530:Surgical Wound Infection / Q000209:etiology* / Q000276:immunology
D023181:Antimicrobial Cationic Peptides; D001798:Blood Proteins; C053368:cationic antimicrobial protein 57, human
Primenenie lizosomal'no-kationnogo testa pri prognozirovanii posleoperatsionnykh gnoĭnykh oslozhneniĭ u bol'nykh infektsionnym éndokarditom.